ATAI Life Sciences N.V.

Ownership Transactions Reported by 20 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	1	+12.6M	97.4%	$2.00	+$25.3M
Sells	6	-334K	2.6%	$1.61	-$537K
Net	-5	+12.3M	94.9%		+$24.7M

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Apeiron Investment Group Ltd.	10%+ Owner	$61.8M	+$25.3M	+69.1%	Mar 24, 2025
Florian Brand	Co-Founder & Co-Chief Executive Officer	$636K	-$291K	-31.4%	Oct 4, 2024
Srinivas Rao	Co-Founder and Chief Executive Officer	$292K	-$102K	-25.8%	Mar 21, 2025
Anne Nagengast Johnson	Chief Financial Officer	$189K	-$45.3K	-19.3%	Mar 21, 2025
Sahil Kirpekar	Chief Business Officer	$156K	-$65.6K	-29.6%	Mar 21, 2025
Glenn Frank Short	Chief Scientific Officer	$57.2K	-$17.8K	-23.7%	Mar 21, 2025
Kevin James Craig	Chief Medical Officer	$11.4K	-$15.6K	-57.8%	Mar 21, 2025
Alexis de Rosnay	Director	$5.39K			May 25, 2022
Gregory L. Weaver	Chief Financial Officer	$5.39K			Mar 2, 2022
Laurent Fischer	Director				Jun 13, 2024
Christian Angermayer	Director, 10%+ Owner				Oct 4, 2024
Rolando Gutierrez-Esteinou	Chief Medical Officer				Mar 14, 2023
Stephen Bardin	Chief Financial Officer				Mar 14, 2023
Amir H. Kalali	Director				Jun 13, 2024
Scott Braunstein	Director				Jun 13, 2024
Andrea Heslin Smiley	Director				Jun 13, 2024
Jason Camm	Director				May 23, 2023
Gerd Kochendoerfer	Chief Operating Officer				Jan 2, 2025
Sabrina Martucci Johnson	Director				Jun 13, 2024
Michael Auerbach	Director				Jun 13, 2024

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.